Glial cytokines in Alzheimer's disease: review and pathogenic implications.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Human Pathology

• Publication date

  1995-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0046-8177(95)90001-2PMID 7635444PMCID PMC3903413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie.

  2005cited by this paper
• Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: Immunocytochemical demonstration of dissociation of two glia-associated proteins

  2004cited by this paper
• Astrocytes and intracerebral immune responses

  2004cited by this paper
• Microglial inter leukin‐1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution

  1995cited by this paper
• INTERLEUKIN-1α EXPRESSION IN BRAIN REGIONS IN ALZHEIMERʼS DISEASE: CORRELATION WITH NEURITIC PLAQUE DISTRIBUTION

  1995cited by this paper
• Interleukin‐1 Expression in Different Plaque Types in Alzheimer's Disease: Significance in Plaque Evalution

  1995cited by this paper
• Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia.

  1994cited by this paper
• Alzheimer's Disease: A Central Role for Amyloid

  1994cited by this paper
• Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression.

  1994cited by this paper
• S100β protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaques

  1994cited by this paper
• S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.

  1994cited by this paper
• Serum tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia.

  1994cited by this paper
• Expression of MRP14, 27E10, interferon-α and leukocyte common antigen by reactive microglia in postmortem human brain tissue

  1994cited by this paper
• Report of Alzheimer's disease Working Group A.

  1994cited by this paper
• In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells.

  1993cited by this paper
• PROCESSING OF NEURONALLY-GENERATED ßAPP BY MACROPHAGES AND MICROGLIA

  1993cited by this paper
• Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta.

  1993cited by this paper
• Involvement of amyloid precursor protein in memory formation in the rat: an indirect antibody approach.

  1993cited by this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

  1993cited by this paper
• Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community‐dwelling elderly persons and their first‐degree relatives

  1993cited by this paper
• Microglia in degenerative neurological disease

  1993cited by this paper
• Alzheimer's disease: prospects for treatment

  1993cited by this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

  1993cited by this paper
• Gliosis in human brain: relationship to size but not other properties of astrocytes.

  1993cited by this paper
• Cytotoxicity of microglia

  1993cited by this paper
• The role of interleukin-1 in disease.

  1993cited by this paper
• Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum.

  1993cited by this paper
• Macrophage colony-stimulating factor in human fetal astrocytes and microglia. Differential regulation by cytokines and lipopolysaccharide, and modulation of class II MHC on microglia.

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• The origin and nature of ramified and amoeboid microglia: A historical review and current concepts

  1993cited by this paper
• A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms.

  1993cited by this paper
• S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo.

  1992cited by this paper
• Regional Differentiation of the Human Fetal Ependyma: Immunocytochemical Markers

  1992cited by this paper
• 5′‐Nucleotidase immunoreactivity of perineuronal microglia responding to rat facial nerve axotomy

  1992cited by this paper
• Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients.

  1992cited by this paper
• Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe

  1992cited by this paper
• Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha.

  1992cited by this paper
• Interleukin 1 and Tumor Necrosis Factor‐α Stimulate the Production of Colony‐Stimulating Factor 1 by Murine Astrocytes

  1992cited by this paper
• Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus.

  1992cited by this paper
• Complement activation by beta-amyloid in Alzheimer disease.

  1992cited by this paper
• Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture

  1992cited by this paper
• Brain macrophages: evaluation of microglia and their functions.

  1992cited by this paper
• The Seminal Role of β‐Amyloid in the Pathogenesis of Alzheimer Disease

  1992cited by this paper
• Cytokine Regulation of Neuronal Survival

  1992cited by this paper
• Head trauma and the risk of Alzheimer's disease.

  1992cited by this paper
• Risk factors in Alzheimer's disease.

  1992cited by this paper
• S100 beta stimulates calcium fluxes in glial and neuronal cells.

  1992cited by this paper
• Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.

  1992cited by this paper
• Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

  1992cited by this paper
• The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease.

  1992cited by this paper
• The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth.

  1992cited by this paper
• Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease.

  1992cited by this paper
• β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

  1992cited by this paper
• Growth control of cultured microglia

  1992cited by this paper
• Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1.

  1992cited by this paper
• Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.

  1991cited by this paper
• beta A4 amyloid protein deposition in brain after head trauma.

  1991cited by this paper
• The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

  1991cited by this paper
• Functions and mechanisms of interleukin 1 in the brain.

  1991cited by this paper
• Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines.

  1991cited by this paper
• Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders.

  1991cited by this paper
• Elevated circulating tumor necrosis factor levels in Alzheimer's disease.

  1991cited by this paper
• Tissue factor antigen in senile plaques of Alzheimer's disease.

  1991cited by this paper
• Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

  1991cited by this paper
• Cytokines in Alzheimer's disease.

  1991cited by this paper
• A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

  1991cited by this paper
• Neurotrophic protein S100 beta stimulates glial cell proliferation.

  1991cited by this paper
• Structure and chromosome assignment of human S100 alpha and beta subunit genes.

  1991cited by this paper
• Are There Clinical and Epidemiological Differences between Familial and Non‐familial Alzheimer's Disease?

  1991cited by this paper
• Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain.

  1991cited by this paper
• Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture.

  1991cited by this paper
• Brain injury and neurologic sequelae

  1991cited by this paper
• Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• βA4 amyloid protein deposition in brain after head trauma

  1991cited by this paper
• Head Trauma as a Risk Factor for Alzheimer's Disease: A Collaborative Re-Analysis of Case-Control Studies

  1991cited by this paper
• Methods in neurosciences

  1991cited by this paper
• Structure and chromosome assignment of human S100 α and β subunit genes

  1991cited by this paper
• Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites

  1991cited by this paper
• Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

  1991cited by this paper
• Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

  1990cited by this paper
• Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits.

  1990cited by this paper
• Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

  1990cited by this paper
• Interleukin-1 stimulates the beta-amyloid precursor protein promoter

  1990cited by this paper
• Reactive astrocytes--a review.

  1990cited by this paper
• Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.

  1990cited by this paper
• Production of colony‐stimulating factor‐1 (CSF‐1) by mouse astroglia in vitro

  1990cited by this paper
• Astrocytes and the plaques of Alzheimer's disease

  1990cited by this paper
• The association between head trauma and Alzheimer's disease.

  1990cited by this paper
• Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

  1990cited by this paper
• Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.

  1989cited by this paper
• Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

  1989cited by this paper
• Activation of the classical complement pathway in brain tissue of Alzheimer patients.

  1989cited by this paper
• The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion

  1989cited by this paper
• Chromosomal localization of murine interleukin-1 α and β genes

  1989cited by this paper
• Monokine production by microglial cell clones

  1989cited by this paper
• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  1989cited by this paper
• The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II

  1989cited by this paper
• Chromosomal localization of murine interleukin-1 alpha and beta genes.

  1989cited by this paper
• Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

  1989cited by this paper

• CD22 modulation alleviates amyloid β-induced neuroinflammation

  2025cites this paper
• Tratamiento de la enfermedad de Alzheimer

  2025cites this paper
• Therapeutic Potential for Cannabidiol on Alzheimer’s Disease-Related Neuroinflammation: A Systematic Review and Meta-Analysis

  2025cites this paper
• Involvement of inflammasomes in the pathogenesis of Alzheimer's disease

  2024cites this paper
• Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology

  2024cites this paper
• Small Molecule Decoy of Amyloid-β Aggregation Blocks Activation of Microglia-Like Cells

  2024cites this paper
• Sodium Thiosulfate: An Innovative Multi-Target Repurposed Treatment Strategy for Late-Onset Alzheimer’s Disease

  2024cites this paper
• Evaluating the Evidence for Neuroprotective and Axonal Regenerative Activities of Different Inflammatory Cell Types After Optic Nerve Injury

  2024cites this paper
• Mechanistic insights into the role of amyloid-β in innate immunity

  2024cites this paper
• N,N-dimethylacetamide targets neuroinflammation in Alzheimer’s disease in in-vitro and ex-vivo models

  2023cites this paper
• Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease

  2023cites this paper
• Effects of intermittent fasting on cognitive health and Alzheimer’s disease

  2023cites this paper
• Recent developments in the role of DNA damage response and understanding its implications for new therapeutic approaches in Alzheimer's disease

  2023cites this paper
• The Impairment of Blood-Brain Barrier in Alzheimer’s Disease: Challenges and Opportunities with Stem Cells

  2022cites this paper
• Diverging Effects of Adolescent Ethanol Exposure on Tripartite Synaptic Development across Prefrontal Cortex Subregions

  2022cites this paper
• Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice

  2022cites this paper
• Targeting Microglia-Synapse Interactions in Alzheimer’s Disease

  2021cites this paper
• Structural characterization of polysaccharide purified from Amanita caesarea and its pharmacological basis for application in Alzheimer's disease: endoplasmic reticulum stress.

  2021cites this paper
• ICAM-1 protects neurons against Amyloid-β and improves cognitive behaviors in 5xFAD mice by inhibiting NF-κB.

  2021cites this paper
• Neuroinflammation and its resolution in Alzheimer's disease

  2021cites this paper
• Neuroimmune Response Mediated by Cytokines in Natural Scrapie after Chronic Dexamethasone Treatment

  2021cites this paper
• Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease.

  2020cites this paper
• Molecular and Therapeutic Aspects of Hyperbaric Oxygen Therapy in Neurological Conditions

  2020cites this paper
• Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review

  2020cites this paper
• Nano-scaled materials may induce severe neurotoxicity upon chronic exposure to brain tissues: A critical appraisal and recent updates on predisposing factors, underlying mechanism, and future prospects.

  2020cites this paper
• The role of glia in protein aggregation.

  2020cites this paper
• Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s disease and frontotemporal lobar degeneration

  2020cites this paper
• Metabolic Regulation of Glial Phenotypes: Implications in Neuron–Glia Interactions and Neurological Disorders

  2020cites this paper
• The Contribution of Formyl Peptide Receptor Dysfunction to the Course of Neuroinflammation: A Potential Role in the Brain Pathology

  2020cites this paper
• Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer’s Disease

  2020cites this paper
• The good, the bad, and the opportunities of the complement system in neurodegenerative disease

  2020cites this paper
• 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner

  2020cites this paper
• Protective Effect of Protocatechuic Acid, Phenolic Compound of Momordica Charantia, against Oxidative Stress and Neuroinflammation in C6 Glial Cell

  2020cites this paper
• PL201, a Reported Rhamnoside Against Alzheimer's Disease Pathology, Alleviates Neuroinflammation and Stimulates Nrf2 Signaling

  2020cites this paper
• Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders

  2020cites this paper
• The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system.

  2019cites this paper
• Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration

  2019cites this paper
• Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease.

  2019cites this paper
• Neuroprotective effects of 1`δ-1`-acetoxyeugenol acetate on Aβ(25-35) induced cognitive dysfunction in mice.

  2019cites this paper
• The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease

  2019cites this paper
• The Full Spectrum of Alzheimer's Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes.

  2019cites this paper
• in Alzheimer's disease

  2018cites this paper
• Inflammation as a central mechanism in Alzheimer's disease

  2018cites this paper
• Altered function of neuronal L-type calcium channels in ageing and neuroinflammation: Implications in age-related synaptic dysfunction and cognitive decline.

  2018cites this paper
• Antiinflammatory Potential of Medicinal Plants: A Source for Therapeutic Secondary Metabolites

  2018cites this paper
• Role of Melatonin in Aluminum-Related Neurodegenerative Disorders: a Review

  2018cites this paper
• Profiling the proteomic inflammatory state of human astrocytes using DIA mass spectrometry

  2018cites this paper
• Lactuca capensis reverses memory deficits in Aβ1‐42‐induced an animal model of Alzheimer's disease

  2017cites this paper
• Altered Serum and Cerebrospinal Fluid Inflammatory Cascades in Mild Cognitive Impairment and Alzheimer’s Disease

  2017influential citation
• Metabolic status of CSF distinguishes rats with tauopathy from controls

  2017cites this paper
• Short-Term Bilateral Adrenalectomy: Biochemical and Morphological Alterations in the Rat Hippocampus

  2017cites this paper
• Aluminum and Neurodegenerative Diseases

  2017cites this paper
• IL-5 blocks apoptosis and tau hyperphosphorylation induced by Aβ25–35 peptide in PC12 cells

  2017cites this paper
• MicroRNAs in Hearing Disorders: Their Regulation by Oxidative Stress, Inflammation and Antioxidants

  2017cites this paper
• Modeling Aggregation of Proliferating Microglia in Response to Amyloid-beta in Dementia

  2017cites this paper
• Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease

  2016cites this paper
• Astrocyte as the Modulator in Brain Inflammation and Neurodegenerative Disorders

  2016cites this paper
• Implication des métabolites de l'APP dans les troubles mnésiques précoces chez la souris TgCRND8, un modèle de la maladie d'Alzheimer

  2016cites this paper
• Aberrant expression of the pore-forming KATP channel subunit Kir6.2 in hippocampal reactive astrocytes in the 3xTg-AD mouse model and human Alzheimer's disease.

  2016cites this paper
• Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer’s Disease

  2016cites this paper
• Purine nucleosides in neuroregeneration and neuroprotection.

  2016cites this paper
• Neuroinflammation: the devil is in the details

  2016cites this paper
• Amyloid-β and amyloid associated proteins in the pathology and diagnosis of Alzheimer's disease

  2016cites this paper
• Reactive gliosis in the pathogenesis of CNS diseases.

  2016cites this paper
• Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer's disease and age-related neurodegeneration.

  2016cites this paper
• Estrogens, inflammation and cognition.

  2016cites this paper
• Title Neuroinflammation in Alzheimer ' s disease Permalink

  2015cites this paper
• Inflammation in Alzheimer’s Disease and Molecular Genetics: Recent Update

  2015cites this paper
• Neuroinflammation in Alzheimer's disease.

  2015cites this paper
• Frontiers in Clinical Drug Research - Alzheimer Disorders

  2015cites this paper
• Microglia in Health and Disease.

  2015cites this paper
• Investigating the impact of anaesthesia and surgery on Alzheimer's disease and the potential therapeutic role of Statin

  2015cites this paper
• EVALUATION OF NOOTROPIC ACTIVTY OF ACOROUS CALAMUS AGAINST SCOPOLAMINE INDUCED ALZHEIMER'S

  2015cites this paper
• Differential Effects of Pioglitazone in the Hippocampal CA1 Region Following Transient Forebrain Ischemia in Low- and High-Fat Diet-Fed Gerbils

  2015cites this paper
• Glia in the pathogenesis of neurodegenerative diseases.

  2014cites this paper
• The role of matrix metalloproteinase-9 in pro-inflammatory factors-induced brain inflammation and neurodegenerative diseases

  2014cites this paper
• Corpora Amylacea in Aging Brain and Age-Related Brain Disorders 

  2014cites this paper
• The Effect of Acute LPS-Induced Immune Activation and Brain Insulin Signaling Disruption in a Diabetic Model of Alzheimer's Disease

  2014cites this paper
• Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients

  2014cites this paper
• Microglia display modest phagocytic capacity for extracellular tau oligomers

  2014cites this paper
• The dual role of astrocyte activation and reactive gliosis.

  2014cites this paper
• Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease

  2014cites this paper
• A systematic review of amyloid-β peptides as putative mediators of the association between affective disorders and Alzheimer׳s disease.

  2014cites this paper
• Activation of microglia and induction of pro-inflammatory cytokines in the hippocampus of type 2 diabetic rats

  2014cites this paper
• 1,8-Cineole (Eucalyptol) Mitigates Inflammation in Amyloid Beta Toxicated PC12 Cells: Relevance to Alzheimer’s Disease

  2014cites this paper
• Astrocyte reactivity and reactive astrogliosis: costs and benefits.

  2014cites this paper
• Proceso inflamatorio en la enfermedad de Alzheimer. Papel de las citoquinas

  2014cites this paper
• UC Irvine UC Irvine Previously Published Works Title Prolonged exposure to low levels of aluminum leads to changes associated with brain aging and neurodegeneration

  2013cites this paper
• On the Way to Longevity: How to Combat Neuro-Degenerative Disease

  2013cites this paper
• Role of Redox Signaling in Neuroinflammation and Neurodegenerative Diseases

  2013cites this paper
• Open‐heart surgery increases cerebrospinal fluid levels of Alzheimer‐associated amyloid β

  2013cites this paper
• Differential pathways for interleukin-1β production activated by chromogranin A and amyloid β in microglia.

  2013cites this paper
• Inflammation in the brain during heart failure

  2013cites this paper
• Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

  2013cites this paper
• The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain.

  2013cites this paper
• Can a combination of nutritional components decrease neuroinflammation in Alzheimer ’ s disease , thereby altering its development ?

  2013cites this paper
• Astrogliosis and HSP 70 activation in neonate rats' brain exposed to sodium metavanadate through lactation.

  2013cites this paper
• Senescence and Senescence-Related Disorders

  2013cites this paper
• Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice

  2013cites this paper
• Location in Query / Remark : click on the Q link to go

  2013cites this paper